Products:Epigenetics and Nuclear Signaling >> Transcription >> Domain Families >> HLH / Leucine Zipper >> Helix-Turn-Helix
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »This product is covered by the Abpromise guarantee. Our scientific support team are available to answer any questions or queries - fill out an inquiry form for ab2769 for help.
Alternatively, you can search the previous enquiries about this product to see if your query has already been answered.
|
|||||||||
|
|||||||||
I would like to know the components in the buffer used for the antibody in the product ab2769. |
|||||||||
ANSWER: |
Thank you for contacting Abcam |
||||||||
|
|||||||||
What are the exact protocol conditions for the IP - especially the concentration of the antibody, the beads and the lysats? |
|||||||||
ANSWER: |
Successful immunoprecipitations were performed with the antibody using Protein A/G agarose affinity resin and antibody concentrations of 5-10 ug mixed with 400 ug of rat brain lysate. The reference below also details an IP application that was done with this product. Citation: Hybridoma, 14(3):279-283, 1995, Author Name: Perdew, G.Title: Production and Characterization of Monoclonal Antibodies Directed against the Ah Receptor. |
||||||||
|
|||||||||
BATCH NUMBER 113233 ORDER NUMBER -- NOT SPECIFIED -- DESCRIPTION OF THE PROBLEM Non-specific staining SAMPLE Tissue PRIMARY ANTIBODY 1:100 DETECTION METHOD DAB kit POSITIVE AND NEGATIVE CONTROLS USED stomarch cancer tissue ANTIBODY STORAGE CONDITIONS -20degree FIXATION OF SAMPLE 10 formalin ANTIGEN RETRIEVAL heating PERMEABILIZATION STEP no treatment BLOCKING CONDITIONS normal goat serum SECONDARY ANTIBODY goat anti Mouse HOW MANY TIMES HAVE YOU TRIED THE APPLICATION? 4 HAVE YOU RUN A "NO PRIMARY" CONTROL? Yes DO YOU OBTAIN THE SAME RESULTS EVERY TIME? Yes WHAT STEPS HAVE YOU ALTERED? I have used this antibody before. But this time there were much non-specific staining. I can show the picture comparing new one and old one. I think this lot have some problem. So I want to receive new one. |
|||||||||
ANSWER: |
Thank you for contacting us for technical support. I understand the customer's protocol worked with a previous lot, could you please provide the two lot numbers and we can check if they arise from the same master stock. Also, can the customer confirm that the protocol is identical in every aspect, has he changed secondary antibody, remembered to block endogenous peroxidases and tried incubating for longer but more dilute antibody? As the antibody is supplied as ascites the new lot may be more concentrated so he may need to dilute the antibody much more. Please pass on those recommendations and provide the lot numbers and I will check if they are from the same master stock, I look forward to hearing from you, Thank you in advance, |
||||||||
|
|||||||||
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
ICC/IF image of ab2769 stained HepG2 cells. The cells were 5% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab2769, in a 1/200 dilution) overnight at +4ºC. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
This was a trial experiment to evaluate the association of AhR to the ABCG2 promoter using ab2769 at a 1/100 dilution for the IP (ChIP assay). Semiquantitative PCR was performed to evaluate the relative association of AhR with the proximal ABCG2 promoter in a S1 colon cancer cell line without treatment, or treated with depsipeptide (10 ng/mL 24h) or benzo(a)pyrene (10uM 24h). Cross-linking (X-ChIP) - 10 Mins 0 Secs Lane 1: DNA ladder (100 bp from promega) Inputs (lanes 2-4): S1 no treatment - serial dilution Inputs (lanes 5-7): S1 treated with depsipeptide - serial dilution Inputs (lanes 8-10): S1 treated with benzo(a)pyrene - serial dilution AhR ChIP (lane 11-13): use 1:1 diluted immunoprecipitate for PCR Lane 11=S1 no treatment lane 12=S1 depsipeptide 10ng/mL lane 13= S1 benzo(a)pyrene 10uM AhR ChIP (lane 14-16): use 1:2 diluted immunoprecipitate for PCR same order as lanes 11-13 Lane 17: H2O control for PCR.
Image courtesy of an anonymous Abreview.
Overlay histogram showing HEK293 cells stained with ab2769 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab2769, 1/20 dilution) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (
6
Call 01223 696 000 or contact us